Surface Taps Ex-Infinity Pharma Exec as New CSO

Xconomy Boston — 

Cambridge, MA-based Surface Oncology has named Vito Palombella its chief scientific officer. Palombella was most recently the executive vice president and CSO of Infinity Pharmaceuticals (NASDAQ: INFI), where he spent almost six years. He held positions at Millennium Pharmaceuticals and LeukoSite before that.